Loading company…
Sonexa Therapeutics develops drug treatments for Alzheimer's disease and related disorders.
Founded in 2007, Sonexa Therapeutics is a clinical-stage biopharmaceutical company developing treatments for Alzheimer's disease and related disorders. Its oral small molecule ST101 crosses the blood-brain barrier and restored learning and memory in animal models of cognitive impairment relevant to Alzheimer's. The company is based in San Diego, US.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in